Is Cabio Biotech (Wuhan) stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Cabio Biotech (Wuhan) pays dividends. Last time was Wednesday 26th of June 2024 where the investors holding the stock on Wednesday 26th of June 2024 were paid CNY0.2 per share. Over the last 5 times between 2020 and 2024, Cabio Biotech (Wuhan) has paid CNY1.78 with an average of CNY0.36 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Cabio Biotech (Wuhan) 10 years ago, but if you had invested on Thursday 19th of December 2019 when the price was CNY32.98, you would have made a loss of CNY-14.36 per share or -43.54%
Yes, the average daily trading liquidity for Cabio Biotech (Wuhan) is CNY2.93 million. You should therefore be able to get in and out of your positions relatively fast.
Cabio Biotech (Wuhan) has no real debt, which is good in periods of high inflation. With a high cash flow to debt ratio of 10.84, the company's ability to pay off the debt is good. Cabio Biotech (Wuhan) has a very good net profit margin of 24.51% and should have very high tolerances against inflation.
We have calculated the inflation risk for Cabio Biotech (Wuhan) to be low [0 of 1]
US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.09 and is down -0.37 over the last 30 days.